Developing Accessible Prescription Drug Labels

October 31, 2012 —The United States Access Board has started an initiative to improve access to prescription drug labels, specifically for individuals who are blind, visually impaired or elderly, following the Food and Drug Administration Safety and Innovation Act (FDASIA) of 2012. A working group, including representatives from industry and various blind and elderly advocacy organizations, will evaluate alternatives such as the inclusion of braille on prescription labels, auditory technology to include “talking bottles”, and radio frequency identification tags. From this evaluation, the working group aims to develop best practices for increasing independent access to information on prescription drug labels.